JMP Securities raised the firm’s price target on Prothena to $85 from $81 and keeps an Outperform rating on the shares following the quarterly results. Headlined by progress on PRX012, Prothena’s broad pipeline continues to advance, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PRTA: